Overview A Study of CL-197 Capsules in Healthy Participants Status: COMPLETED Trial end date: 2024-01-20 Target enrollment: Participant gender: Summary The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of CL-197 capsules in health conditions.Phase: PHASE1 Details Lead Sponsor: Henan Genuine Biotech Co., Ltd.